Company · Healthtech & Bio

Kanara

kanaralabs.com ↗ ·Santa Cruz de Tenerife ·Pre-seed

Kanara (Kanara Labs) is a Spanish deeptech biotech that produces plant-derived active compounds — resveratrol, polyphenols, cannabinoids, active pharmaceutical ingredients and biofuel precursors — via in vitro plant cell culture in modular bioreactors with non-GMO stem cells, avoiding land-intensive farming. Founded in 2021 and based in Tenerife (Canary Islands), it is a small pre-seed/grant-funded team (~2-10 people) targeting the pharma, cosmetics and nutraceutical industries, and in 2026 became the only Spanish company selected for the EU's EIC Pre-Accelerator, winning a €499,000 grant; it also works with energy group Moeve on cellular-agriculture biofuels. Its funding to date is public grants and accelerator programmes, ~$570K in total.

Founded
2021
Founders
4
News
3
Rounds
0
Investors
3
SectorsBiotechnology, Cellular agriculture, Pharmaceuticals, Cosmetics ingredients, Agtech, Sustainability Start-up MapHealthtech & Bio › R&D tools & software for life sciences

Profile updated 22 Aug 2026

Founders

Eduardo W. Jørgensen
Scientific Affairs & Co-Founder
Jorge Gutiérrez
CTO & Co-Founder
Leopoldo Machado
CEO & Co-Founder
Raúl Clemente
CFO & Co-Founder

Global models

No comparables on record yet.

Investors 3

Funding rounds

No announced rounds on record.

News & media 3

Start typing to search across everything.
↑↓ navigate↵ openesc close